Klaria Pharma Holding AB (publ) receives 24.5 MSEK through directed new issue

As previously communicated on October 14, 2020, the Board of Directors of Klaria Pharma Holding AB (publ) (“Klaria” or “the Company”) resolved on a directed new issue of a maximum of 4,239,766 shares with a subscription price of SEK 6.84 per share, which corresponds to a gross payment of a maximum of approximately SEK 29 million (the “Share Issue”). The Board's resolution was approved at the Extraordinary General Meeting of the Company on November 2, 2020. Klaria hereby announces that the company has now received approximately SEK 24.5 million through the Share Issue and that 3 581 871 shares have been subscribed for.

For further information on the transaction, please see the press release on the Board's resolution, which was published on 14 October 2020.

Download as PDF